Agarwal H, Huffstetler HE, Lopez C, Go VF, Napravnik S, Farel CE, Rutstein SE. “I Feel Like I Don’t Even Have HIV Anymore”-Facilitators, Barriers, andExperience regarding Use of Long-Acting Injectable Antiretroviral Therapy AmongPersons with HIV in North Carolina. AIDS Patient Care STDS. 2024Jul;38(7):324-329. doi: 10.1089/apc.2024.0076. Epub 2024 Jun 11. PMID: 38860413;PMCID: PMC12054693.
Aldredge A, Mehta CC, Lahiri CD, Schneider MF, Alcaide ML, Anastos K, PlankeyM, French AL, Floris-Moore M, Tien PC, Dionne J, Dehovitz J, Collins LF, ShethAN. Consequences of low-level viremia among women with HIV in the United States.AIDS. 2024 Nov 1;38(13):1829-1838. doi: 10.1097/QAD.0000000000003990. Epub 2024Aug 28. PMID: 39110550; PMCID: PMC11424065.
Althoff KN, Stewart C, Humes E, Gerace L, Boyd C, Gebo K, Justice AC, HyleEP, Coburn SB, Lang R, Silverberg MJ, Horberg MA, Lima VD, Gill MJ, Karris M,Rebeiro PF, Thorne J, Rich AJ, Crane H, Kitahata M, Rubtsova A, Wong C, Leng S,Marconi VC, D’Souza G, Kim HN, Napravnik S, McGinnis K, Kirk GD, Sterling TR,Moore RD, Kasaie P. The forecasted prevalence of comorbidities andmultimorbidity in people with HIV in the United States through the year 2030: Amodeling study. PLoS Med. 2024 Jan 12;21(1):e1004325. doi:
10.1371/journal.pmed.1004325. PMID: 38215160; PMCID: PMC10833859.
Amico KR, Mayer KH, Landovitz RJ, Marzinke M, Hendrix C, McCauley M, WilkinT, Gulick R; HPTN 069/A5305 study team. Influence of Participant Perceptions ofAdherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069Analysis of Self-Reported Adherence Experiences While on Study. AIDS Behav. 2024Mar;28(3):1058-1067. doi: 10.1007/s10461-023-04215-9. Epub 2023 Nov 10. PMID:37947968; PMCID: PMC10896804.
Anderko RR, DePuyt AE, Bronson R, Bullotta AC, Aga E, Bosch RJ, Jones RB,Eron JJ, Mellors JW, Gandhi RT, McMahon DK, Macatangay BJ, Rinaldo CR, MailliardRB. Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy. J Immunol. 2024 May 15;212(10):1564-1578. doi:10.4049/jimmunol.2300672. PMID: 38551350; PMCID: PMC11073922.
Aouizerat BE, Garcia JN, Domingues CV, Xu K, Quach BC, Page GP, Konkle-ParkerD, Bolivar HH, Lahiri CD, Golub ET, Cohen MH, Kassaye SG, DeHovitz J, KuniholmMH, Archin NM, Tien PC, Hancock DB, Johnson EO. Frequent Cocaine Use isAssociated With Larger HIV Latent Reservoir Size. J Acquir Immune Defic Syndr.2024 Oct 1;97(2):156-164. doi: 10.1097/QAI.0000000000003472. PMID: 39250649;PMCID: PMC11752676.
Appleton AA, Kuniholm MH, Vásquez E, Cohen MH, Donohue J, Floris-Moore M,Friedman MR, Hanna DB, Mimiaga MJ, Moran CA, Plankey MW, Teplin LA, Shitole SG,Ware D, Jones DL, Wise J. Life course history of physical and sexual abuse isassociated with cardiovascular disease risk among women living with and withoutHIV. AIDS. 2024 Apr 1;38(5):739-750. doi: 10.1097/QAD.0000000000003822. Epub2023 Dec 20. PMID: 38126350; PMCID: PMC10939824.
Ashokkumar M, Mei W, Peterson JJ, Harigaya Y, Murdoch DM, Margolis DM,Kornfein C, Oesterling A, Guo Z, Rudin CD, Jiang Y, Browne EP. IntegratedSingle-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulatorsof Viral Reactivation. Genomics Proteomics Bioinformatics. 2024 May9;22(1):qzae003. doi: 10.1093/gpbjnl/qzae003. PMID: 38902848; PMCID:PMC11189801.Bell GJ, Chen JS, Maierhofer CN, Matoga M, Rutstein SE, Lancaster KE, Chagomerana MB, Jere E, Mmodzi P, Bonongwe N, Mathiya E, Ndalama B, HosseinipourMC, Emch M, Dennis AM, Cohen MS, Hoffman IF, Miller WC, Powers KA. Updated RiskScore Algorithms for Acute HIV Infection Detection at a Sexually TransmittedInfections Clinic in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2024 Dec15;97(5):450-459. doi: 10.1097/QAI.0000000000003519. PMID: 39250334; PMCID:PMC11723808.
Bhattacharya R, Uddin MM, Patel AP, Niroula A, Finneran P, Bernardo R, FitchKV, Lu MT, Bloomfield GS, Malvestutto C, Aberg JA, Fichtenbaum CJ, Hornsby W,Ribaudo HJ, Libby P, Ebert BL, Zanni MV, Douglas PS, Grinspoon SK, Natarajan P.Risk factors for clonal hematopoiesis of indeterminate potential in people withHIV: a report from the REPRIEVE trial. Blood Adv. 2024 Feb 27;8(4):959-967. doi:10.1182/bloodadvances.2023011324. PMID: 38197863; PMCID: PMC10877123.
Blair J, Kempf MC, Dionne JA, Causey-Pruitt Z, Wise JM, Jackson EA, MuntnerP, Hanna DB, Kizer JR, Fischl MA, Ofotokun I, Adimora AA, Gange SJ, Brill IK,Levitan EB. Disparities in Hypertension Prevalence, Awareness, Treatment, andControl Among Women Living With and Without HIV in the US South. Open ForumInfect Dis. 2023 Dec 18;11(1):ofad642. doi: 10.1093/ofid/ofad642. PMID:38196400; PMCID: PMC10776242.
Blair J, Kempf MC, Dionne JA, Causey-Pruitt Z, Wise JM, Jackson EA, MuntnerP, Hanna DB, Kizer JR, Fischl MA, Ofotokun I, Ramirez C, Gange SJ, Brill IK,Levitan EB. Awareness, treatment, and control of hypertension among women atrisk or living with HIV in the US South. AIDS. 2024 Sep 1;38(11):1703-1713. doi:10.1097/QAD.0000000000003960. Epub 2024 Jun 19. PMID: 38905486; PMCID:PMC11293969.
Brazier E, Tymejczyk O, Wools-Kaloustian K, Jiamsakul A, Torres MTL, Lee JS,Abuogi L, Khol V, Mejía Cordero F, Althoff KN, Law MG, Nash D; Internationalepidemiology Databases to Evaluate AIDS (IeDEA). Long-term HIV care outcomesunder universal HIV treatment guidelines: A retrospective cohort study in 25countries. PLoS Med. 2024 Mar 18;21(3):e1004367. doi:10.1371/journal.pmed.1004367. PMID: 38498589; PMCID: PMC10962811.
Bui HTM, Giang LM, Chen JS, Sripaipan T, Nong HTT, Nguyen NTK, Bartels SM,Rossi SL, Hutton H, Chander G, Sohn H, Ferguson O, Tran HV, Nguyen MX, NguyenKD, Rutstein SE, Levintow S, Hoffman IF, Powell BJ, Pence BW, Go VF, Miller WC.A Brief Alcohol Intervention (BAI) to reduce alcohol use and improve PrEPoutcomes among men who have sex with men in Vietnam: study protocol for arandomized controlled trial. Trials. 2024 Aug 21;25(1):552. doi:10.1186/s13063-024-08382-5. PMID: 39164770; PMCID: PMC11337901.
Burdorf RM, Zhou S, Amon C, Long N, Hill CS, Adams L, Tegha G, ChagomeranaMB, Jumbe A, Maliwichi M, Wallie S, Li Y, Swanstrom R, Hosseinipour MC. Impactof Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutationson Antiretroviral Therapy Outcomes. J Infect Dis. 2024 Jul 25;230(1):86-94. doi:10.1093/infdis/jiae131. PMID: 39052733; PMCID: PMC11272071.
Chandran A, Feng X, Coburn SB, Kasaie P, Malone J, Horberg MA, Hogan B,Rebeiro PF, Gill MJ, McGinnis KA, Silverberg MJ, Karris MY, Napravnik S, Konkle-Parker D, Lee J, Freeman AM, Ghidey R, Garza V, Marconi VC, Kirk GD, Thorne J,Crane HM, Lang R, Kitahata MM, Moore RD, Althoff KN. The Contribution ofSocioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Carein the NA-ACCORD. J Acquir Immune Defic Syndr. 2024 Nov 1;97(3):232-241. doi:10.1097/QAI.0000000000003486. PMID: 39431507; PMCID: PMC11494146.
Chow FC, Nance RM, Becker K, Ho EL, Huffer A, Kalani R, Marra CM, Zunt JR,Bamford L, Burkholder GA, Cachay E, Eron JJ, Keruly J, Kitahata MM, Napravnik S,Saag MS, Willig AL, Moore RD, Tirschwell DL, Delaney JA, Crane HM; as the CFARNetwork of Integrated Clinical Systems (CNICS) Cohort Study. Sex Differences inthe Risk of Stroke Associated With Traditional and Non-Traditional Factors in aUS Cohort of People With HIV Infection. Neurology. 2024 Aug 27;103(4):e209726.doi: 10.1212/WNL.0000000000209726. Epub 2024 Aug 1. PMID: 39088772; PMCID:PMC11793864.
Clutton GT, Weideman AMK, Mischell MA, Kallon S, Conrad SZ, Shaw FR, WarrenJA, Lin L, Kuruc JD, Xu Y, Gay CM, Armistead PM, G Hudgens M, Goonetilleke NP.CD3 downregulation identifies high-avidity human CD8 T cells. Clin Exp Immunol.2024 Feb 19;215(3):279-290. doi: 10.1093/cei/uxad124. PMID: 37950348; PMCID:PMC10876116.
Coburn SB, Pimentel N, Leyden W, Kitahata MM, Moore RD, Althoff KN, Gill MJ,Lang R, Horberg MA, D’Souza G, Hussain SK, Dubrow R, Novak RM, Rabkin CS, ParkLS, Sterling TR, Neugebauer RS, Silverberg MJ; North American AIDS CohortCollaboration on Research and Design of the International EpidemiologicDatabases to Evaluate AIDS. Brief Report: Protease Inhibitors VersusNonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer AmongPeople With HIV. J Acquir Immune Defic Syndr. 2024 Aug;96(4):393-398. doi:10.1097/QAI.0000000000003436. PMID: 39720558; PMCID: PMC11665951.
Cooper SE, Zhang S, Haines D, Mayer KH, Amico KR, Landovitz RJ, Hendrix CW,Marzinke MA, Chege W, McCauley M, Gulick RM. Pharmacologic Drug Detection andSelf-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial. AIDS Behav.2024 Nov;28(11):3710-3718. doi: 10.1007/s10461-024-04451-7. Epub 2024 Jul 31.PMID: 39083151; PMCID: PMC11471692.
Crane HM, Nance RM, Ruderman SA, Haidar L, Tenforde MW, Heckbert SR, BudoffMJ, Hahn AW, Drumright LN, Ma J, Mixson LS, Lober WB, Barnes GS, McReynolds J,Attia EF, Peter I, Moges T, Bamford L, Cachay E, Mathews WC, Christopolous K,Hunt PW, Napravnik S, Keruly J, Moore RD, Burkholder G, Willig AL, Lindstrom S,Whitney BM, Saag MS, Kitahata MM, Crothers KA, Delaney JAC. VenousThromboembolism Among People With HIV: Design, Implementation, and Findings of aCentralized Adjudication System in Clinical Care Sites Across the United States.J Acquir Immune Defic Syndr. 2024 Feb 1;95(2):207-214. doi:10.1097/QAI.0000000000003339. PMID: 37988634; PMCID: PMC11151789.
Crane HM, Nance RM, Ruderman SA, Drumright LN, Mixson LS, Heckbert SR,Feinstein MJ, Budoff MJ, Bamford L, Cachay E, Napravnik S, Moore RD, Keruly J,Willig AL, Burkholder GA, Hahn A, Ma J, Fredericksen R, Saag MS, Chander G,Kitahata MM, Crothers K, Mayer KH, O’Cleirigh C, Cropsey K, Whitney BM, DelaneyJAC. Smoking and Type 1 Versus Type 2 Myocardial Infarction Among People WithHIV in the United States: Results from the Center for AIDS Research NetworkIntegrated Clinical Systems Cohort. J Assoc Nurses AIDS Care. 2024 Nov-Dec01;35(6):507-518. doi: 10.1097/JNC.0000000000000492. Epub 2024 Sep 6. PMID:39241219.
Crawford TN, Neilands TB, Drumright LN, Fredericksen RJ, Johnson MO, MayerKH, Bamford L, Batchelder AW, Crane HM, Elopre L, Moore RD, Rosengren AL,Christopoulos KA. Internalized HIV stigma and viral suppression: examining themediating and moderating roles of substance use and social support. AIDS. 2024Dec 1;38(15):2064-2072. doi: 10.1097/QAD.0000000000003999. Epub 2024 Aug 28.PMID: 39206880; PMCID: PMC11666411.
Crowell TA, Ritz J, Zheng L, Naqvi A, Cyktor JC, Puleo J, Clagett B, LamaJR, Kanyama C, Little SJ, Cohn SE, Riddler SA, Collier AC, Heath SL,Tantivitayakul P, Grinsztejn B, Arduino RC, Rooney JF, van Zyl GU, Coombs RW,Fox L, Ananworanich J, Eron JJ, Sieg SF, Mellors JW, Daar ES; AIDS ClinicalTrials Group (ACTG) A5354/EARLIER Study Team. Impact of antiretroviral therapyduring acute or early HIV infection on virologic and immunologic outcomes:results from a multinational clinical trial. AIDS. 2024 Jul 1;38(8):1141-1152.doi: 10.1097/QAD.0000000000003881. Epub 2024 Mar 13. PMID: 38489580; PMCID:PMC11323228.
Curnow AC, Huang L, Fischl MA, Floris-Moore M, Morris A, Nouraie M, ReddyDB, Seaberg EC, Sheth AN, Tien PC, Wang RJ. Hepatitis C Virus Clearance andDiffusing Capacity for Carbon Monoxide in Women With and Without HumanImmunodeficiency Virus. Open Forum Infect Dis. 2024 May 2;11(5):ofae251. doi:10.1093/ofid/ofae251. PMID: 38770208; PMCID: PMC11103618.
Cyktor JC, Yeh E, Ribaudo H, Hoeth D, Naqvi A, Bell T, Ridker PM,Fichtenbaum C, Daar ES, Havlir D, Tawakol A, Lederman MM, Stein JH, Deeks SG,Currier JS, Hsue PY, Mellors JW; A5314 Team. Brief Report: Low-Dose MethotrexateDoes Not Affect Measures of HIV-1 Persistence in Individuals With ChronicallyTreated HIV-1 Infection. J Acquir Immune Defic Syndr. 2024 Aug 15;96(5):481-485.doi: 10.1097/QAI.0000000000003453. PMID: 39287554; PMCID: PMC11408752.
deFilippi C, McCallum S, Zanni MV, Fitch KV, Diggs MR, Bloomfield GS,Fichtenbaum CJ, Aberg JA, Malvestutto CD, Pinto-Martinez A, Stapleton A, DugganJ, Robbins GK, Taron J, Karady J, Foldyna B, Lu MT, Ribaudo HJ, Douglas PS,Grinspoon SK. Association of Cardiac Troponin T With Coronary Atherosclerosis inAsymptomatic Primary Prevention People With HIV. JACC Adv. 2024 Aug16;3(9):101206. doi: 10.1016/j.jacadv.2024.101206. PMID: 39253712; PMCID:PMC11381782.
Deshmukh AA, Lin YY, Damgacioglu H, Shiels M, Coburn SB, Lang R, Althoff KN,Moore R, Silverberg MJ, Nyitray AG, Chhatwal J, Sonawane K, Sigel K. Recent andprojected incidence trends and risk of anal cancer among people with HIV inNorth America. J Natl Cancer Inst. 2024 Sep 1;116(9):1450-1458. doi:10.1093/jnci/djae096. PMID: 38713084; PMCID: PMC11378305.
Dickey BL, Yanik EL, Thompson Z, Burkholder G, Kitahata MM, Moore RD,Jacobson J, Mathews WC, Christopoulos KA, Fleming J, Napravnik S, Achenbach C,Coghill AE. The Association of HIV Control and Immunosuppression With Risk ofNon-AIDS-Defining Cancer Risk Among Patients on Antiretroviral Therapy. J AcquirImmune Defic Syndr. 2024 Mar 1;95(3):275-282. doi: 10.1097/QAI.0000000000003350.PMID: 37977197; PMCID: PMC11146681.
Drumright LN, Johnson MO, Mayer KH, Christopoulos K, Cachay E, Crawford TN,Whitney BM, Dai M, Ruderman SA, Mixson LS, Keruly JC, Chander G, Saag MS,Kitahata MM, Moore RD, Willig AL, Eron JJ, Napravnik S, Nance RM, Hahn A, Ma J,Bamford L, Fredericksen RJ, Delaney JAC, Crane HM. Differences in internalizedHIV stigma across subpopulations of people with HIV in care across the UnitedStates. AIDS. 2024 Jul 1;38(8):1206-1215. doi: 10.1097/QAD.0000000000003864.Epub 2024 Feb 9. PMID: 38349228; PMCID: PMC11144440.
Duarte MJ, Tien PC, Kardashian A, Ma Y, Hunt P, Kuniholm MH, Adimora AA,Fischl MA, French AL, Topper E, Konkle-Parker D, Minkoff H, Ofotokun I, PlankeyM, Sharma A, Price JC. Microbial Translocation and Gut Damage Are AssociatedWith an Elevated Fast Score in Women Living With and Without HIV. Open ForumInfect Dis. 2024 Mar 30;11(5):ofae187. doi: 10.1093/ofid/ofae187. PMID:38680610; PMCID: PMC11055391.
Edrosolan KA, Shlipak MG, Scherzer R, Estrella MM, Gustafson D, Karim R,Fisher M, Cohen M, Kassaye S, Dumond J, Abraham A, McCulloch CE, Ascher SB.Mediation analysis of chronic kidney disease risk factors using kidneybiomarkers in women living with HIV. AIDS. 2024 May 1;38(6):813-824. doi:10.1097/QAD.0000000000003839. Epub 2024 Jan 12. PMID: 38224361; PMCID:PMC11025668.
Edupuganti S, Hurt CB, Stephenson KE, Huang Y, Paez CA, Yu C, Yen C, HanscomB, He Z, Miner MD, Gamble T, Heptinstall J, Seaton KE, Domin E, Lin BC, McKee K,Doria-Rose N, Regenold S, Spiegel H, Anderson M, McClosky N, Zhang L, Piwowar-Manning E, Ackerman ME, Pensiero M, Dye BJ, Landovitz RJ, Mayer K, Siegel M,Sobieszczyk M, Walsh SR, Gama L, Barouch DH, Montefiori DC, Tomaras GD; HVTN136/HPTN 092 Study Team. Safety, tolerability, pharmacokinetics, andneutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LSadministered alone and in combination with VRC07-523LS in adults without HIV inthe USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlledphase 1 trial. Lancet HIV. 2025 Jan;12(1):e13-e25. doi: 10.1016/S2352-3018(24)00247-9. Epub 2024 Dec 10. PMID: 39667379; PMCID: PMC11795396.
Edwards JK, Cole SR, Zivich PN, Hudgens MG, Breger TL, Shook-Sa BE.Semiparametric g-computation for survival outcomes with time-fixed exposures: Anillustration. Ann Epidemiol. 2024 Aug;96:24-31. doi:10.1016/j.annepidem.2024.05.013. Epub 2024 Jun 3. PMID: 38838873; PMCID:PMC11283356.
Eron JJ, Little SJ, Crofoot G, Cook P, Ruane PJ, Jayaweera D, VanderVeen LA,DeJesus E, Zheng Y, Mills A, Huang H, Waldman SE, Ramgopal M, Gorgos L, CollinsSE, Baeten JM, Caskey M. Safety of teropavimab and zinlirvimab with lenacapavironce every 6 months for HIV treatment: a phase 1b, randomised, proof-of-conceptstudy. Lancet HIV. 2024 Mar;11(3):e146-e155. doi: 10.1016/S2352-3018(23)00293-X.Epub 2024 Jan 30. PMID: 38307098; PMCID: PMC12245405.
Eron JJ, Ramgopal M, Osiyemi O, Mckellar M, Slim J, DeJesus E, Arora P,Blair C, Hindman JT, Wilkin A. Bictegravir/emtricitabine/tenofovir alafenamidein adults with HIV-1 and end-stage kidney disease on chronic haemodialysis. HIVMed. 2025 Feb;26(2):302-307. doi: 10.1111/hiv.13721. Epub 2024 Oct 6. PMID:39370144; PMCID: PMC11786611.
Fenton AD, Archin N, Turner A-M, Joseph S, Moeser M, Margolis DM, Browne EP.A novel high-throughput microwell outgrowth assay for HIV-infected cells. JVirol. 2024 Mar 19;98(3):e0179823. doi: 10.1128/jvi.01798-23. Epub 2024 Feb 20.PMID: 38376258; PMCID: PMC10949454.
Fitch KV, Zanni MV, Manne-Goehler J, Diggs MR, Gattu AK, Currier JS,Bloomfield GS, Hsiao CB, Gupta SK, Aberg JA, Malvestutto CD, Fichtenbaum CJ, LuMT, Douglas PS, Ribaudo HJ, Grinspoon SK. Diabetes Risk Factors in People WithHIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention: A Randomized Trial. Ann Intern Med. 2024 Nov;177(11):1449-1461. doi:10.7326/ANNALS-24-00944. Epub 2024 Oct 8. PMID: 39374532; PMCID: PMC11573625.
Fogel JM, Piwowar-Manning E, Moser A, Hill T, Ahmed S, Cummings V, MostafaHH, Wang Z, Jennings A, Gallardo-Cartagena JA, Figueroa MI, St Clair M, RinehartAR, Adeyeye A, Rooney JF, Cohen MS, Grinsztejn B, Landovitz RJ, Eshleman SH;HPTN 083 Study Team. Evaluation of Xpert point-of-care assays for detection ofHIV infection in persons using long-acting cabotegravir for pre-exposureprophylaxis. Microbiol Spectr. 2024 Jul 9;12(8):e0030724. doi:10.1128/spectrum.00307-24. Epub ahead of print. PMID: 38980027; PMCID:
PMC11302132.
Fredericksen RJ, Baker R, Sibley A, Estadt AT, Colston D, Mixson LS, WaltersS, Bresett J, Levander XA, Leichtling G, Davy-Mendez T, Powell M, Stopka TJ, PhoM, Feinberg J, Ezell J, Zule W, Seal D, Cooper HLF, Whitney BM, Delaney JAC,Crane HM, Tsui JI. Motivation and context of concurrent stimulant and opioid useamong persons who use drugs in the rural United States: a multi-site qualitativeinquiry. Harm Reduct J. 2024 Apr 1;21(1):74. doi: 10.1186/s12954-024-00986-z.PMID: 38561753; PMCID: PMC10985853.
Fredericksen RJ, Mixson LS, Drumright LN, Nance RM, Delaney JAC, RudermanSA, Whitney BM, Hahn A, Ma J, Mayer KH, Christopoulos KA, Willig AL, NapravnikS, Bamford L, Cachay E, Eron JJ, Saag M, Jacobson J, Kitahata MM, Crane HM.Correlates of Intimate Partner Violence, Including Psychological PartnerViolence, in a Multisite U.S. Cohort of People in HIV Care. AIDS Behav. 2024Sep;28(9):3170-3183. doi: 10.1007/s10461-024-04402-2. Epub 2024 Jul 16. PMID:39014029; PMCID: PMC11390320.
Fujita AW, Ramakrishnan A, Mehta CC, Yusuf OB, Thompson AB, Shoptaw S,Carrico AW, Adimora AA, Eaton E, Cohen MH, Jain JP, Adedimeji A, Plankey M,Jones DL, Chandran A, Colasanti JA, Sheth AN. Co-Utilization of HIV, SubstanceUse, Mental Health Services Among Women With Current Substance Use:Opportunities for Integrated Care? J Prim Care Community Health. 2024 Jan-Dec;15:21501319241285531. doi: 10.1177/21501319241285531. PMID: 39327860; PMCID: PMC11437548.
Gay CL, Hanley PJ, Falcinelli SD, Kuruc JD, Pedersen SM, Kirchherr J, RainesSLM, Motta CM, Lazarski C, Chansky P, Tanna J, Shibli A, Datar A, McCann CD,Sili U, Ke R, Eron JJ, Archin N, Goonetilleke N, Bollard CM, Margolis DM. TheEffects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded SpecificT-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIVon Antiretroviral Therapy. J Infect Dis. 2024 Mar 14;229(3):743-752. doi:10.1093/infdis/jiad423. PMID: 38349333; PMCID: PMC10938201.
Gay CL, Bosch RJ, McKhann A, Cha R, Morse GD, Wimbish CL, Campbell DM,Moseley KF, Hendrickx S, Messer M, Benson CA, Overton ET, Paccaly A, Jankovic V,Miller E, Tressler R, Li JZ, Kuritzkes DR, Macatangay BJC, Eron JJ, Hardy WD;A5370 Team. Safety and Immune Responses Following Anti-PD-1 Monoclonal AntibodyInfusions in Healthy Persons With Human Immunodeficiency Virus on AntiretroviralTherapy. Open Forum Infect Dis. 2024 Jan 11;11(3):ofad694. doi:10.1093/ofid/ofad694. PMID: 38449916; PMCID: PMC10917183.
Giron LB, Liu Q, Adeniji OS, Yin X, Kannan T, Ding J, Lu DY, Langan S, ZhangJ, Azevedo JLLC, Li SH, Shalygin S, Azadi P, Hanna DB, Ofotokun I, Lazar J,Fischl MA, Haberlen S, Macatangay B, Adimora AA, Jamieson BD, Rinaldo C,Merenstein D, Roan NR, Kutsch O, Gange S, Wolinsky SM, Witt MD, Post WS,Kossenkov A, Landay AL, Frank I, Tien PC, Gross R, Brown TT, Abdel-Mohsen M.Immunoglobulin G N-glycan markers of accelerated biological aging during chronicHIV infection. Nat Commun. 2024 Apr 10;15(1):3035. doi:10.1038/s41467-024-47279-4. PMID: 38600088; PMCID: PMC11006954.
González-Scarano F, Napravnik S, Vance DE. Frailty and HIV-associatedneurocognitive disorder are only modestly associated. AIDS. 2024 Apr1;38(5):757-759. doi: 10.1097/QAD.0000000000003842. Epub 2024 Mar 14. PMID:38482907; PMCID: PMC12184770.
Grinspoon SK, Ribaudo HJ, Douglas PS. Trial Update of Pitavastatin toPrevent Cardiovascular Events in HIV Infection. N Engl J Med. 2024 May2;390(17):1626-1628. doi: 10.1056/NEJMc2400870. PMID: 38692296; PMCID:PMC11403456.
Gustafson DR, Shi Q, Thurn M, Holman S, Kuniholm MH, Fischl M, Floris-MooreM, Gange S, Konkle-Parker D, Plankey M, Price JC, Ross RD, Rubtsova A, Sharma A,Hoover DR. Frailty-Related Factors among Women Living with and without HIV Aged40 Years and Older. The Women’s Interagency HIV Study. J Frailty Aging.2024;13(1):40-49. doi: 10.14283/jfa.2023.41. PMID: 38305442; PMCID: PMC11776730.
Haidar L, Crane HM, Nance RM, Webel A, Ruderman SA, Whitney BM, Willig AL,Napravnik S, Mixson LS, Leong C, Lavu A, Aboulatta L, Dai M, Hahn A, Saag MS,Bamford L, Cachay E, Kitahata MM, Mayer KH, Jacobson J, Moore RD, Delaney JAC,Drumright LN, Eltonsy S. Weight loss associated with semaglutide treatment amongpeople with HIV. AIDS. 2024 Mar 15;38(4):531-535. doi:10.1097/QAD.0000000000003791. Epub 2023 Nov 16. PMID: 37976053; PMCID:PMC10922142.
Haw NJL, Lesko CR, Ng DK, Lam J, Lang R, Kitahata MM, Crane H, Eron J Jr,Gill MJ, Horberg MA, Karris M, Loutfy M, McGinnis KA, Moore RD, Althoff K, AgwuA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).Incidence of non-AIDS defining comorbidities among young adults with perinatallyacquired HIV in North America. AIDS. 2024 Jul 15;38(9):1366-1374. doi:10.1097/QAD.0000000000003892. Epub 2024 Mar 19. PMID: 38507583; PMCID:PMC11211058.
Honeycutt JB, Wahl A, Files JK, League AF, Yadav-Samudrala BJ, Garcia JV,Fitting S. In situ analysis of neuronal injury and neuroinflammation duringHIV-1 infection. Retrovirology. 2024 Jul 1;21(1):11. doi:10.1186/s12977-024-00644-z. PMID: 38945996; PMCID: PMC11215835.
Hyle EP, Wattananimitgul N, Mukerji SS, Foote JHA, Reddy KP, Thielking A, YuL, Viswanathan A, Rubin LH, Shebl FM, Althoff KN, Freedberg KA. Age-associateddementia among older people aging with HIV in the United States: a modelingstudy. AIDS. 2024 Jul 1;38(8):1186-1197. doi: 10.1097/QAD.0000000000003862. Epub2024 Feb 7. PMID: 38329107; PMCID: PMC11141339.
Jacobson JM, Felber BK, Chen H, Pavlakis GN, Mullins JI, De Rosa SC,Kuritzkes DR, Tomaras GD, Kinslow J, Bao Y, Olefsky M, Rosati M, Bear J,Heptinstall JR, Zhang L, Sawant S, Hannaman D, Laird GM, Cyktor JC, Heath SL,Collier AC, Koletar SL, Taiwo BO, Tebas P, Wohl DA, Belaunzaran-Zamudio PF,McElrath MJ, Landay AL; ACTG 5369 Study Team. The immunogenicity of an HIV-1 Gagconserved element DNA vaccine in people with HIV and receiving antiretroviraltherapy. AIDS. 2024 Jun 1;38(7):963-973. doi: 10.1097/QAD.0000000000003804. Epub2023 Dec 1. PMID: 38051788; PMCID: PMC11062837.
Jain JP, Heise MJ, Lisha NE, Moreira CH, Glidden DV, Burkholder GA, CraneHM, Jacobson JM, Cachay ER, Mayer KH, Napravnik S, Moore RD, Dawson-Rose C,Johnson MO, Christopoulos KA, Gandhi M, Spinelli MA. Impact of the CoronavirusDisease 2019 Pandemic on Substance Use Disorder Risk Among People Living WithHuman Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: AnInterrupted Time Series Analysis. Open Forum Infect Dis. 2024 Aug26;11(9):ofae491. doi: 10.1093/ofid/ofae491. PMID: 39252870; PMCID: PMC11382144.
Jones KF, Long DM, Bair MJ, Agil D, Browne L, Burkholder G, Clay OJ, ConderK, Durr AL, Farel CE, King K, Johnson B, Liebschutz JM, Demonte W, Leone M,Mullen L, Orris SM, Thomas T, Johnson M, Napravnik S, Merlin JS. Efficacy of aPain Self-Management Intervention Tailored to People With HIV: A RandomizedClinical Trial. JAMA Intern Med. 2024 Sep 1;184(9):1074-1082. doi:10.1001/jamainternmed.2024.3071. PMID: 39008317; PMCID: PMC11250263.
Joseph SB, Abrahams MR, Moeser M, Tyers L, Archin NM, Council OD, SondgerothA, Spielvogel E, Emery A, Zhou S, Doolabh D, Ismail SD, Karim SA, Margolis DM,Pond SK, Garrett N, Swanstrom R, Williamson C. The timing of HIV-1 infection ofcells that persist on therapy is not strongly influenced by replicationcompetency or cellular tropism of the provirus. PLoS Pathog. 2024 Feb29;20(2):e1011974. doi: 10.1371/journal.ppat.1011974. PMID: 38422171; PMCID:PMC10931466.
Karady J, Lu MT, Bergström G, Mayrhofer T, Taron J, Foldyna B, Paradis K,McCallum S, Aberg JA, Currier JS, Fitch KV, Fulda ES, Bloomfield GS, Overton ET,Lind L, Östgren CJ, Elvstam O, Söderberg S, Jernberg T, Pepe R, Dubé MP, MushattD, Fichtenbaum CJ, Malvestutto C, Zanni MV, Hoffmann U, Ribaudo H, Grinspoon SK,Douglas PS. Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Communityand Symptomatic Higher-Risk Populations. JACC Adv. 2024 May 3;3(6):100968. doi:10.1016/j.jacadv.2024.100968. PMID: 38938873; PMCID: PMC11198107.
Kaur H, Alluri RK, Wu K, Kalayjian RC, Bush WS, Palella FJ, Koletar SL,Hileman CO, Erlandson KM, Ellis RJ, Bedimo RJ, Taiwo BO, Tassiopoulos KK,Kallianpur AR; ACTG A5322 Study Team. Sex-Biased Associations of CirculatingFerroptosis Inhibitors with Reduced Lipid Peroxidation and Better NeurocognitivePerformance in People with HIV. Antioxidants (Basel). 2024 Aug 28;13(9):1042.doi: 10.3390/antiox13091042. PMID: 39334701; PMCID: PMC11429126.
Kebede S, Brazier E, Freeman AM, Muwonge TR, Choi JY, de Waal R, Poda A,Cesar C, Munyaneza A, Kasozi C, Pasayan MKU, Althoff KN, Shongo A, Low N,Ekouevi D, Veloso VG, Ross J; International Epidemiology Databases to EvaluateAIDS (IeDEA). Preexposure prophylaxis availability among health facilitiesparticipating in the global International epidemiology Databases to EvaluateAIDS (IeDEA) consortium. AIDS. 2024 Apr 1;38(5):751-756. doi:10.1097/QAD.0000000000003824. Epub 2023 Dec 21. PMID: 38133656; PMCID:PMC10939841.
Konkle-Parker D, Cleveland JD, Long D, Nair V, Fischl M, Wingood G, EdmondsA. Population Density and Health Outcomes in Women with HIV in the SouthernUnited States: A Retrospective Longitudinal Analysis. J Womens Health (Larchmt).2024 Aug;33(8):1111-1119. doi: 10.1089/jwh.2023.0698. Epub 2024 Jun 12. PMID:38864119; PMCID: PMC11698682.
Lancaster KE, Stockton M, Remch M, Wester CW, Nash D, Brazier E, AdedimejiA, Finlayson R, Freeman A, Hogan B, Kasozi C, Kwobah EK, Kulzer JL, Merati T,Tine J, Poda A, Succi R, Twizere C, Tlali M, Groote PV, Edelman EJ, ParcesepeAM; IeDEA Consortium. Availability of substance use screening and treatmentwithin HIV clinical sites across seven geographic regions within the IeDEAconsortium. Int J Drug Policy. 2024 Feb;124:104309. doi:10.1016/j.drugpo.2023.104309. Epub 2024 Jan 15. PMID: 38228025; PMCID:PMC10939808.
Landovitz RJ, Delany-Moretlwe S, Fogel JM, Marzinke MA, Piwowar-Manning E,Richardson P, Halvas EK, Mellors JW, Persaud D, Kofron R, McCauley M, Rose S,Rinehart AR, Rooney JF, Adeyeye A, Cohen MS, Donnell D, Hosseinipour MC,Grinsztejn B, Eshleman SH; HPTN 083 and 084 Study Teams. Features of HIVInfection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis. NEngl J Med. 2024 Oct 3;391(13):1253-1256. doi: 10.1056/NEJMc2402088. Epub 2024Jul 24. PMID: 39046350; PMCID: PMC11598663.
Lang R, Coburn SB, Gill MJ, Justice AC, Grossman J, Gebo KA, Horberg MA,Mayor AM, Silverberg MJ, McGinnis KA, Hogan B, Moore RD, Althoff KN; NorthAmerican AIDS Cohort Collaboration on Research, Design (NA-ACCORD) of theInternational Epidemiologic Databases to Evaluate AIDS (IeDEA). Evaluation ofmean corpuscular volume among anemic people with HIV in North America followingART initiation. AIDS Res Ther. 2024 Aug 7;21(1):52. doi:10.1186/s12981-024-00641-4. PMID: 39113038; PMCID: PMC11304803.
Lang R, Coburn SB, Gill MJ, Grossman J, Gebo KA, Horberg MA, Mayor AM,Justice AC, Bosch RJ, Silverberg MJ, Rabkin CS, Sterling TR, Thorne JE, MooreRD, Althoff KN; North American AIDS Cohort Collaboration on Research and Design(NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS(IeDEA). The Association of Anemia With Survival Among People With HIV FollowingAntiretroviral Initiation in the NA-ACCORD 2007-2016. J Acquir Immune DeficSyndr. 2024 Dec 1;97(4):334-343. doi: 10.1097/QAI.0000000000003502. PMID:39118208; PMCID: PMC11732725.
Lauckner C, Krajewski T, Mollan K, Nowotny KM, McLouth CJ, Oser CB,Brinkley-Rubinstein L. Associations Between Sexual Minority Status, HazardousDrinking, and Discrimination Experiences Among Criminal Legal-Involved Adults inthe Southern PrEP Cohort (SPECS) Study. Subst Use Misuse. 2024;59(12):1751-1757.doi: 10.1080/10826084.2024.2374972. Epub 2024 Jul 10. PMID: 38987993; PMCID:PMC11421969.
Lee SK, Sondgeroth A, Xu Y, Warren J, Zhou S, Gilleece M, Hauser BM, Gay CL,Kuruc JD, Archin NM, Eron JJ, Margolis DM, Goonetilleke N, Swanstrom R. SequenceAnalysis of Inducible, Replication-Competent Virus Reveals No Evidence of HIV-1Evolution During Suppressive Antiviral Therapy, Indicating a Lack of OngoingViral Replication. Open Forum Infect Dis. 2024 Apr 17;11(5):ofae212. doi:10.1093/ofid/ofae212. PMID: 38756763; PMCID: PMC11097118.
Ling L, Kim M, Soper A, Kovarova M, Spagnuolo RA, Begum N, Kirchherr J,Archin N, Battaglia D, Cleveland D, Wahl A, Margolis DM, Browne EP, Garcia JV.Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir.mBio. 2024 Sep 11;15(9):e0163224. doi: 10.1128/mbio.01632-24. Epub 2024 Aug 13.PMID: 39136440; PMCID: PMC11389399.
Li JZ, Melberg M, Kittilson A, Abdel-Mohsen M, Li Y, Aga E, Bosch RJ,Wonderlich ER, Kinslow J, Giron LB, Di Germanio C, Pilkinton M, MacLaren L,Keefer M, Fox L, Barr L, Acosta E, Ananworanich J, Coombs R, Mellors J, Deeks S,Gandhi RT, Busch M, Landay A, Macatangay B, Smith DM; AIDS Clinical Trials GroupA5345 Study Team. Predictors of HIV rebound differ by timing of antiretroviraltherapy initiation. JCI Insight. 2024 Feb 8;9(3):e173864. doi:10.1172/jci.insight.173864. PMID: 38329130; PMCID: PMC10967395.
Lu MT, Ribaudo H, Foldyna B, Zanni MV, Mayrhofer T, Karady J, Taron J, FitchKV, McCallum S, Burdo TH, Paradis K, Hedgire SS, Meyersohn NM, DeFilippi C,Malvestutto CD, Sturniolo A, Diggs M, Siminski S, Bloomfield GS, Alston-Smith B,Desvigne-Nickens P, Overton ET, Currier JS, Aberg JA, Fichtenbaum CJ, HoffmannU, Douglas PS, Grinspoon SK; REPRIEVE Trial Writing Group. Effects ofPitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV:Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial. JAMA Cardiol.2024 Apr 1;9(4):323-334. doi: 10.1001/jamacardio.2023.5661. Erratum in: JAMACardiol. 2024 May 1;9(5):487. doi: 10.1001/jamacardio.2024.0582. PMID: 38381407;PMCID: PMC10882511.
Mann SC, Tong W, Abraham AG, Palella F, Sharma A, Tien PC, Fischl MA,McFarlane SI, Lahiri CD, Koletar S, Merenstein D, Floris-Moore M, Lake JE,Daubert E, Hickman A, Brown TT, Castillo-Mancilla J. The impact of diabetesmellitus on HIV virologic control: results of the MACS/WIHS combined cohortstudy. AIDS. 2024 Nov 15;38(14):1922-1931. doi: 10.1097/QAD.0000000000003978.Epub 2024 Jul 18. PMID: 39028112; PMCID: PMC11884325.
Ma J, Delaney JAC, Ruderman SA, Nance RM, Hahn AW, Drumright LN, Whitney BM,Fredericksen RJ, Mixson LS, Merrill JO, Safren SA, Mayer KH, O’Cleirigh C,Napravnik S, Chander G, Moore RD, Christopoulos KA, Willig AL, Bamford L, WebelA, McCaul ME, Cachay ER, Jacobson JM, Saag MS, Kitahata MM, Crane HM, WilliamsEC. Severity and Number of Substances Used are Independently Associated withAntiretroviral Therapy Adherence Over Time among People with HIV in the CurrentTreatment Era. AIDS Behav. 2025 Feb;29(2):468-479. doi:10.1007/s10461-024-04532-7. Epub 2024 Oct 28. Erratum in: AIDS Behav. 2025Feb;29(2):480-481. doi: 10.1007/s10461-024-04566-x. PMID: 39465466.
Ma J, Luu B, Ruderman SA, Whitney BM, Merrill JO, Mixson LS, Nance RM,Drumright LN, Hahn AW, Fredericksen RJ, Chander G, Lau B, McCaul ME, Safren S,O’Cleirigh C, Cropsey K, Mayer KH, Mathews WC, Moore RD, Napravnik S,Christopoulos K, Willig A, Jacobson JM, Webel A, Burkholder G, Mugavero MJ, SaagMS, Kitahata MM, Crane HM, Delaney JAC. Alcohol and drug use severity areindependently associated with antiretroviral adherence in the current treatmentera. AIDS Care. 2024 May;36(5):618-630. doi: 10.1080/09540121.2023.2223899. Epub2023 Jul 7. PMID: 37419138; PMCID: PMC10771542.
McCrimmon T, Collins LF, Pereyra M, Platamone C, Perez-Brumer A, Shaffer VA,Kerrigan D, Sheth AN, Cohen MH, Hanna DB, Ramirez C, Gange SJ, Rana A, Tamraz B,Goparaju L, Wilson TE, Alcaide M, Philbin MM. Likelihood of Trying Long-ActingInjectable Antiretroviral Therapy Among Women With HIV in Nine Sites Across theUnited States. J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):e23-e27. doi:10.1097/QAI.0000000000003422. PMID: 38905479; PMCID: PMC11250912.
Medaglio D, Bilker WB, Han X, Merlin JS, Plankey M, Martin J, Crane HM,Hojat LS, Bamford L, Schnoll R, Tyndale RF, Ashare RL, Gross R. NicotineMetabolite Ratio Decreases After Switching Off Efavirenz-Based Therapy in PeopleWith HIV Who Smoke. Clin Pharmacol Ther. 2024 Jan;115(1):80-85. doi:10.1002/cpt.3068. Epub 2023 Oct 20. PMID: 37787039; PMCID: PMC10752215.
Montaño M, Shapiro AE, Whitney BM, Bamford L, Burkholder G, Cachay ER,Christopoulos KA, Crane HM, Delaney JAC, Eron JJ, Fredericksen RJ, Hunt PW,Jacobson JM, Keruly JC, Kim HN, Mayer KH, Moore RD, Napravnik S, Pettit A, SaagMS, Yendewa GA, Kitahata MM, Bender Ignacio RA. Mpox in People With HumanImmunodeficiency Virus: Predictors of Diagnosis, Outcomes, and VaccineEffectiveness in a Multisite Cohort. Clin Infect Dis. 2024 Oct 8:ciae464. doi:10.1093/cid/ciae464. Epub ahead of print. PMID: 39377755.
Murphy K, Shi Q, Hoover DR, Adimora AA, Alcaide ML, Brockmann S, Daubert E,Duggal P, Merenstein D, Dionne JA, Sheth AN, Keller MJ, Herold BC, Anastos K,Aouizerat B. Genetic predictors for bacterial vaginosis in women living with andat risk for HIV infection. Am J Reprod Immunol. 2024 May;91(5):e13845. doi:10.1111/aji.13845. PMID: 38720636; PMCID: PMC11410097.
Ngongondo M, Ritz J, Hughes MD, Matoga M, Hosseinipour MC; AIDS ClinicalTrials Group A5208, A5221, A5175 and A5274 Study Teams. Discontinuation oftenofovir disoproxil fumarate from initial ART regimens because of renal adverseevents: An analysis of data from four multi-country clinical trials. PLOS GlobPublic Health. 2024 Jan 4;4(1):e0002648. doi: 10.1371/journal.pgph.0002648.PMID: 38175824; PMCID: PMC10766173.
Nguyen MX, Bartels SM, Akiba CF, Sripaipan T, Nong HT, Dang LT, Tran HV,Hoang VT, Le GM, Go VF, Miller WC, Powell BJ. Tracking modifications toimplementation strategies: a case study from SNaP – a hybrid type III randomizedcontrolled trial to scale up integrated systems navigation and psychosocialcounseling for PWID with HIV in Vietnam. BMC Med Res Methodol. 2024 Oct26;24(1):249. doi: 10.1186/s12874-024-02367-3. PMID: 39462341; PMCID:PMC11520046.
Oliveira VHF, Willig AL, Horvat Davey C, Buford TW, Menezes P, Cachay E,Crane HM, Burkholder GA, Gripshover BM, Fleming JG, Cleveland JD, Webel AR.Brief Report: Relationship Between Adiposity and Biomarkers of Aging and FrailtyAmong Adults Aging With HIV. J Acquir Immune Defic Syndr. 2024 Apr1;95(4):377-382. doi: 10.1097/QAI.0000000000003362. PMID: 38100820; PMCID:PMC10922782.
Overton ET, Kantor A, Fitch KV, Mosepele M, Aberg JA, Fichtenbaum CJ,McComsey GA, Malvestutto C, Lu MT, Negredo E, Bernardino J, Hickman AB, DouglasPS, Grinspoon SK, Zanni M, Ribaudo H, Wyatt C; REPRIEVE Trial Investigators.Proteinuria and albuminuria among a global primary cardiovascular diseaseprevention cohort of people with HIV. AIDS. 2025 Jan 1;39(1):31-39. doi:10.1097/QAD.0000000000004016. Epub 2024 Sep 13. PMID: 39283736; PMCID:PMC11624062.
Park JW, Wilson-Barthes MG, Dulin AJ, Hogan JW, Mugavero MJ, Napravnik S,Carey MP, Fava JL, Dale SK, Earnshaw VA, Johnson B, Dougherty-Sheff S, Agil D,Howe CJ. Multilevel Resilience and HIV Virologic Suppression Among AfricanAmerican/Black Adults in the Southeastern United States. J Racial Ethn HealthDisparities. 2024 Feb;11(1):313-325. doi: 10.1007/s40615-023-01520-w. Epub 2023Apr 12. Erratum in: J Racial Ethn Health Disparities. 2024 Sep 23. doi:10.1007/s40615-024-02163-1. PMID: 37043167; PMCID: PMC10092932.
Parra-Rodriguez L, O’Halloran J, Wang Y, Jin W, Dastgheyb RM, Spence AB,Sharma A, Gustafson DR, Milam J, Weber KM, Adimora AA, Ofotokun I, Fischl MA,Konkle-Parker D, Maki PM, Xu Y, Rubin LH. Common antiretroviral combinations areassociated with somatic depressive symptoms in women with HIV. AIDS. 2024 Feb1;38(2):167-176. doi: 10.1097/QAD.0000000000003730. Epub 2023 Sep 28. PMID:37773048; PMCID: PMC11833910.
Peters BA, Whalen A, Xue X, Topper EF, Weber KM, Tien PC, Kassaye SG,Minkoff H, Fox E, Fischl MA, Collins LF, Floris-Moore M, Hodis HN, Qi Q, HannaDB, Sharma A, Anastos K, Kaplan RC. Subclinical Atherosclerosis Across theMenopausal Transition in Women With and Without HIV. J Infect Dis. 2024 Mar14;229(3):780-785. doi: 10.1093/infdis/jiad488. PMID: 37947273; PMCID:PMC10938198.
Raines SLM, Falcinelli SD, Peterson JJ, Van Gulck E, Allard B, Kirchherr J,Vega J, Najera I, Boden D, Archin NM, Margolis DM. Nanoparticle delivery of Tatsynergizes with classical latency reversal agents to express HIV antigentargets. Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0020124. doi:10.1128/aac.00201-24. Epub 2024 Jun 3. Erratum in: Antimicrob Agents Chemother.2025 Aug 6;69(8):e0081725. doi: 10.1128/aac.00817-25. PMID: 38829049; PMCID:PMC11232404.
Rajdev L, Jackie Wang CC, Joshi H, Lensing S, Lee J, Ramos JC, Baiocchi R,Ratner L, Rubinstein PG, Ambinder R, Henry D, Streicher H, Little RF, Chiao E,Dittmer DP, Einstein MH, Cesarman E, Mitsuyasu R, Sparano JA; AIDS MalignancyConsortium. Assessment of the safety of nivolumab in people living with HIV withadvanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095Study. Cancer. 2024 Mar 15;130(6):985-994. doi: 10.1002/cncr.35110. Epub 2023Nov 14. PMID: 37962072; PMCID: PMC10922055.
Ramakrishnan A, Fujita AW, Mehta CC, Wilson TE, Shoptaw S, Carrico A,Adimora AA, Eaton EF, Jones DL, Chandran A, Sheth AN. Brief Report: SubstanceUse Care Continuum in Women With and Without HIV in the Southern United States.J Acquir Immune Defic Syndr. 2024 Apr 15;95(5):424-430. doi:10.1097/QAI.0000000000003373. Epub 2024 Mar 11. PMID: 38133580; PMCID:PMC10927302.
Rebeiro PF, Thome JC, Gange SJ, Althoff KN, Berry SA, Horberg MA, Moore RD,Silverberg MJ, Sack DE, Sterling TR, Sant’Anna P, Shepherd BE. The impact ofMedicaid expansion under the Affordable Care Act on HIV care continuum outcomesacross the United States. Health Aff Sch. 2024 Oct 7;2(10):qxae128. doi:10.1093/haschl/qxae128. PMID: 39445109; PMCID: PMC11498052.
Ruderman SA, Drumright LN, Delaney JAC, Webel AR, Fitzpatrick AL, WhitneyBM, Nance RM, Hahn AW, Ma J, Mixson LS, Eltonsy S, Willig AL, Mayer KH,Napravnik S, Greene M, McCaul M, Cachay E, Kritchevsky SB, Austad SN, Landay A,Saag MS, Kitahata MM, Lau B, Lesko C, Chander G, Crane HM, Odden MC. Evaluatingthe Sick Quitting Hypothesis for Frailty Status and Reducing Alcohol Use AmongPeople With HIV in a Longitudinal Clinical Cohort Study. J Assoc Nurses AIDSCare. 2024 Jan-Feb 01;35(1):e1-e2. doi: 10.1097/JNC.0000000000000445. PMID:38150573; PMCID: PMC10753926.
Ruderman SA, Willig AL, Cleveland JD, Burkholder G, Davey CH, Fleming J,Gripshover B, Katundu M, Buford TW, Jones R, Saag MS, Delaney JAC, Crane HM,Webel AR. Low food security is associated with frailty status and frailtycomponents among people with HIV. AIDS. 2025 Jan 1;39(1):57-63. doi:10.1097/QAD.0000000000004006. Epub 2024 Sep 3. PMID: 39229756; PMCID:PMC11624057.
Ruderman SA, Hunt PW, Beck-Engeser G, Ambayec G, Willig AL, Saag MS,Napravnik S, Cachay E, Bamford L, Landay A, Drumright LN, Mixson LS, Whitney BM,Nance RM, Kitahata MM, Crane HM, Delaney JAC, Hahn AW. Biomarkers of microbialtranslocation and generalized inflammation are associated with frailty amongpeople with HIV. AIDS. 2025 Feb 1;39(2):153-161. doi:10.1097/QAD.0000000000004047. Epub 2024 Oct 24. PMID: 39453872; PMCID:PMC11717601.
Ruderman SA, Nance RM, Crane HM, Cachay E, Kitahata MM, Napravnik S, WhitneyBM, Heckbert SR, Attia EF, Longenecker CT, Hoffmann AP, Budoff MJ, Ma J,Christopoulos K, Hunt PW, Moore RD, Keruly JC, Burkholder G, Bamford L, WilligAL, Chander G, Saag MS, Drumright LN, Feinstein MJ, Crothers K, Delaney JAC.Cumulative HIV viral load and lower CD4 + cell count are associated withincident venous thromboembolism in people with HIV. AIDS. 2025 Apr1;39(5):579-583. doi: 10.1097/QAD.0000000000004095. Epub 2024 Dec 17. PMID:39693493; PMCID: PMC11908933.
Rutstein SE, Lopez C, Davy-Mendez T, Agarwal H, Huffstetler H, Perhac A,Turner B, Eron JJ, Go V, Farel CE, Li KP, Napravnik S. Characterizing long-acting injectable antiretroviral therapy eligibility and initiation at a safetynet academic medical center in the southeastern United States. Int J STD AIDS.2025 Jan;36(1):47-55. doi: 10.1177/09564624241289998. Epub 2024 Oct 3. PMID:39361721; PMCID: PMC11833706.
Salazar J, Lisha NE, Neilands TB, Ludwig-Barron N, Johnson MO, Cachay ER,Napravnik S, Crane HM, Moore RD, Fredericksen RJ, Mayer KH, Christopoulos KA,Sauceda JA. The HIV Index Is Associated With Retention in Care Among LatinxPersons Living With HIV in the CFAR Network of Integrated Clinical SystemsCohort. AIDS Educ Prev. 2024 Aug;36(4):261-271. doi: 10.1521/aeap.2024.36.4.261.PMID: 39189958.
Semenova L, Wang Y, Falcinelli S, Archin N, Cooper-Volkheimer AD, MargolisDM, Goonetilleke N, Murdoch DM, Rudin CD, Browne EP. Machine learning approachesidentify immunologic signatures of total and intact HIV DNA during long-termantiretroviral therapy. Elife. 2024 Sep 9;13:RP94899. doi: 10.7554/eLife.94899.PMID: 39250423; PMCID: PMC11383529.
Shahid A, MacLennan S, Jones BR, Sudderuddin H, Dang Z, Cobarrubias K,Duncan MC, Kinloch NN, Dapp MJ, Archin NM, Fischl MA, Ofotokun I, Adimora A,Gange S, Aouizerat B, Kuniholm MH, Kassaye S, Mullins JI, Goldstein H, Joy JB,Anastos K, Brumme ZL; MACS/WIHS combined cohort study (MWCSS). The replication-competent HIV reservoir is a genetically restricted, younger subset of theoverall pool of HIV proviruses persisting during therapy, which is highlygenetically stable over time. J Virol. 2024 Feb 20;98(2):e0165523. doi:10.1128/jvi.01655-23. Epub 2024 Jan 12. PMID: 38214547; PMCID: PMC10878278.
Shahid A, Jones BR, Duncan MC, MacLennan S, Dapp MJ, Kuniholm MH, AouizeratB, Archin NM, Gange S, Ofotokun I, Fischl MA, Kassaye S, Goldstein H, Anastos K,Joy JB, Brumme ZL. A simple phylogenetic approach to analyze hypermutated HIVproviruses reveals insights into their dynamics and persistence duringantiretroviral therapy. Virus Evol. 2024 Nov 11;11(1):veae094. doi:10.1093/ve/veae094. PMID: 39802824; PMCID: PMC11724191.
Shook-Sa BE, Zivich PN, Rosin SP, Edwards JK, Adimora AA, Hudgens MG, ColeSR. Fusing trial data for treatment comparisons: Single vs multi-span bridging.Stat Med. 2024 Feb 20;43(4):793-815. doi: 10.1002/sim.9989. Epub 2023 Dec 18.PMID: 38110289; PMCID: PMC10843571.
Shook-Sa BE, Hudgens MG, Knittel AK, Edmonds A, Ramirez C, Cole SR, Cohen M,Adedimeji A, Taylor T, Michel KG, Kovacs A, Cohen J, Donohue J, Foster A, FischlMA, Long D, Adimora AA. EXPOSURE EFFECTS ON COUNT OUTCOMES WITH OBSERVATIONAL DATA, WITH APPLICATION TO INCARCERATED WOMEN. Ann Appl Stat. 2024 Sep;18(3):2147-2165. doi: 10.1214/24-aoas1874. Epub 2024 Aug 5. PMID: 39493307;PMCID: PMC11526847.
Spinelli MA, Christopoulos KA, Moreira CV, Jain JP, Lisha N, Glidden DV,Burkholder GA, Crane HM, Shapiro AE, Jacobson JM, Cachay ER, Mayer KH, Napravnik S, Moore RD, Gandhi M, Johnson MO. Viral Suppression Trajectories DestabilizedAfter Coronavirus Disease 2019 Among US People With Human ImmunodeficiencyVirus: An Interrupted Time Series Analysis. Clin Infect Dis. 2024 Apr10;78(4):991-994. doi: 10.1093/cid/ciad657. PMID: 37963086; PMCID: PMC11006098.
Spinelli MA, Johnson MO, Lisha NE, Jain JP, Moreira CV, Glidden DV,Burkholder GA, Crane HM, Jacobson JM, Cachay ER, Mayer KH, Napravnik S, MooreRD, Gandhi M, Christopoulos KA. Prevalence and Correlates of SARS-CoV-2 VaccineUptake and Hesitancy Among People With HIV Across the United States. J AcquirImmune Defic Syndr. 2024 Sep 1;97(1):13-18. doi: 10.1097/QAI.0000000000003466.PMID: 39116328; PMCID: PMC11315354.
Sugarman J, Weir BW, Dun C, Gulick RM, Wilkin TJ, Mayer KH, McCauley M,Weinfurt KP. Expectations of preventative benefits and risk behaviors in arandomized trial evaluating oral HIV preexposure prophylaxis candidates. AIDSCare. 2024 Aug;36(8):1172-1178. doi: 10.1080/09540121.2024.2332446. Epub 2024Apr 12. PMID: 38606559; PMCID: PMC11288779.
Tierney HR, Ma Y, Bacchetti P, Adimora AA, Chandran A, Kempf MC, CollinsLF, DeHovitz J, DiClemente RJ, French AL, Jones DL, Sharma A, Spence AB, HahnJA, Price JC, Tien PC. Pivoting from in-person to phone survey assessment ofalcohol and substance use: effects on representativeness in a United Statesprospective cohort of women living with and without HIV. Am J Drug AlcoholAbuse. 2024 Jan 2;50(1):54-63. doi: 10.1080/00952990.2023.2267745. Epub 2023 Nov13. PMID: 37956200; PMCID: PMC10939835.
Trickey A, Glaubius R, Pantazis N, Zangerle R, Wittkop L, Vehreschild J,Grabar S, Cavassini M, Teira R, d’Arminio Monforte A, Casabona J, van Sighem A,Jarrin I, Ingle SM, Sterne JAC, Imai-Eaton JW, Johnson LF. Estimation ofImprovements in Mortality in Spectrum Among Adults With HIV ReceivingAntiretroviral Therapy in High-Income Countries. J Acquir Immune Defic Syndr.2024 Jan 1;95(1S):e89-e96. doi: 10.1097/QAI.0000000000003326. Epub 2024 Jan 4.PMID: 38180742; PMCID: PMC10769170.
Trickey A, McGinnis K, Gill MJ, Abgrall S, Berenguer J, Wyen C, HessamfarM, Reiss P, Kusejko K, Silverberg MJ, Imaz A, Teira R, d’Arminio Monforte A,Zangerle R, Guest JL, Papastamopoulos V, Crane H, Sterling TR, Grabar S, IngleSM, Sterne JAC. Longitudinal trends in causes of death among adults with HIV onantiretroviral therapy in Europe and North America from 1996 to 2020: acollaboration of cohort studies. Lancet HIV. 2024 Mar;11(3):e176-e185. doi:10.1016/S2352-3018(23)00272-2. Epub 2024 Jan 24. PMID: 38280393; PMCID:PMC11656032.
Valerio LA, Rzepka MC, Davy-Mendez T, Williams A, Perhac A, Napravnik S,Berkowitz SA, Farel CE, Durr AL. Food Insecurity Prevalence and Risk Factorsamong Persons with HIV in a Southeastern US Clinical Care Setting. AIDS Behav.2025 Jan;29(1):45-54. doi: 10.1007/s10461-024-04497-7. Epub 2024 Sep 13. PMID:39266889; PMCID: PMC11844217.
Vance DE, Xu Y, Dastgheyb R, Maki PM, Zhang J, Springer G, Anastos K,Gustafson DR, Weber KM, Dykxhoorn DM, Milam J, Diaz MM, Kassaye SG, Waldrop D,Lee J, Kempf MC, Konkle-Parker D, Goodkin K, Leviner AJ, Wright M, Jones D,Rubin LH. Does cognitive intra-individual variability predict change in everydayfunctioning performance in women with and without HIV in the Women’s InteragencyHIV Study? Appl Neuropsychol Adult. 2024 Dec 24:1-11. doi:10.1080/23279095.2024.2444573. Epub ahead of print. PMID: 39718250; PMCID:PMC12185775.
VanderVeen LA, Selzer L, Moldt B, Parvangada A, Li J, Ananworanich J,Crowell TA, Eron JJ, Daar ES, Haubrich R, Geleziunas R, Cyktor J, Mellors JW,Callebaut C. HIV-1 envelope diversity and sensitivity to broadly neutralizingantibodies across stages of acute HIV-1 infection. AIDS. 2024 Mar15;38(4):607-610. doi: 10.1097/QAD.0000000000003792. Epub 2023 Nov 16. PMID:38416554; PMCID: PMC10906214.
Wahl A, Yao W, Liao B, Chateau M, Richardson C, Ling L, Franks A, SenthilK, Doyon G, Li F, Frost J, Whitehurst CB, Pagano JS, Fletcher CA, Azcarate-PerilMA, Hudgens MG, Rogala AR, Tucker JD, McGowan I, Sartor RB, Garcia JV. A germ-free humanized mouse model shows the contribution of resident microbiota tohuman-specific pathogen infection. Nat Biotechnol. 2024 Jun;42(6):905-915. doi:10.1038/s41587-023-01906-5. Epub 2023 Aug 10. PMID: 37563299; PMCID:PMC11073568.
Walsh SR, Gay CL, Karuna ST, Hyrien O, Skalland T, Mayer KH, SobieszczykME, Baden LR, Goepfert PA, Del Rio C, Pantaleo G, Andrew P, Karg C, He Z, Lu H,Paez CA, Baumblatt JAG, Polakowski LL, Chege W, Anderson MA, Janto S, Han X,Huang Y, Dumond J, Ackerman ME, McDermott AB, Flach B, Piwowar-Manning E, Seaton K, Tomaras GD, Montefiori DC, Gama L, Mascola JR; HVTN 127/HPTN 087 Study Team.Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial. PLoS Med. 2024 Jun 24;21(6):e1004329. doi: 10.1371/journal.pmed.1004329. PMID: 38913710; PMCID:PMC11251612.
Wilson-Barthes MG, Park JW, Mugavero MJ, Napravnik S, Carey MP, Fava JL,Dale SK, Earnshaw VA, Agil D, Howe CJ, Dulin AJ. Multilevel Resilience andAppointment Attendance Among African American/Black Adults with HIV: AProspective Multisite Cohort Study. Epidemiology. 2025 Jan 1;36(1):99-106. doi:10.1097/EDE.0000000000001801. Epub 2024 Oct 10. PMID: 39589016; PMCID:PMC11599769.
Wohl DA, Spinner CD, Flamm J, Hare CB, Doblecki-Lewis S, Ruane PJ, MolinaJM, Mills A, Brinson C, Ramgopal M, Clarke A, Crofoot G, Martorell C, Carter C,Cox S, Hojilla JC, Shao Y, Das M, Kintu A, Baeten JM, Grant RM, Mounzer K, MayerK. HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER):week 144 open-label extension of a randomised, controlled, phase 3 trial. LancetHIV. 2024 Aug;11(8):e508-e521. doi: 10.1016/S2352-3018(24)00130-9. Epub 2024 Jul14. PMID: 39008999.
Xia C, Chander G, Hutton HE, McCaul ME, Delaney JA, Mayer KH, Jacobson JM,Puryear S, Crane HM, Shapiro AE, Cachay ER, Lau B, Napravnik S, Saag M, LeskoCR. Association of Alcohol Use with COVID-19 Infection and Hospitalization AmongPeople Living with HIV in the United States, 2020. AIDS Behav. 2024May;28(5):1795-1807. doi: 10.1007/s10461-024-04301-6. Epub 2024 Feb 29. PMID:38421512; PMCID: PMC11238908.
Zanni MV, Umbleja T, Fichtenbaum CJ, Fitch KV, McCallum S, Aberg JA,Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Schnittman SR, ErlandsonKM, Diggs MR, Foldyna B, Martinez E, Somboonwit C, Wang GP, Mushatt D, ConnickE, Lu MT, Douglas PS, Ribaudo HJ, Grinspoon SK. Effects of Pitavastatin onCOVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV.Open Forum Infect Dis. 2024 Oct 10;11(10):ofae574. doi: 10.1093/ofid/ofae574.PMID: 39435321; PMCID: PMC11493083.
Zivich PN, Cole SR, Edwards JK, Glidden DV, Das M, Shook-Sa BE, Shao Y,Mehrotra ML, Adimora AA, Eron JJ. HIV Prevention Among Men Who Have Sex WithMen: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus Placebo. JInfect Dis. 2024 Apr 12;229(4):1123-1130. doi: 10.1093/infdis/jiad507. PMID:37969014; PMCID: PMC11011171.
Zou RS, Ruan Y, Truong B, Bhattacharya R, Lu MT, Karády J, Bernardo R,Finneran P, Hornsby W, Fitch KV, Ribaudo HJ, Zanni MV, Douglas PS, Grinspoon SK,Patel AP, Natarajan P. Polygenic Scores and Preclinical Cardiovascular Diseasein Individuals With HIV: Insights From the REPRIEVE Trial. J Am Heart Assoc.2024 Apr 2;13(7):e033413. doi: 10.1161/JAHA.123.033413. Epub 2024 Mar 27. PMID:38533953; PMCID: PMC11179771.
Zuñiga J, Thurman W, West Ohueri C, Cho E, Chineyemba P, Martin CA, MathewsWC, Christopoulos K, Davy-Mendez T, García AA. Construction of a TheoreticalModel of Chronic Disease Self-Management: Self-Management Within a Syndemic. ANSAdv Nurs Sci. 2025 Apr-Jun 01;48(2):166-176. doi: 10.1097/ANS.0000000000000526.Epub 2024 Sep 5. PMID: 39235280; PMCID: PMC11880358.